NCT04691765View on ClinicalTrials.gov

Anakinra in Previously Untreated Chronic Lymphocytic Leukemia Patients

PHASE1UnknownINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

May 1, 2021

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2022

Conditions

Chronic Lymphocytic Leukemia

Interventions

DRUG

Kineret

escalating doses of drug will be administered to 3 groups of 4 patients for 7 months

Sponsors

Collaborators (1)

Swedish Orphan Biovitrum

All Listed Sponsors

collaborator

Swedish Orphan Biovitrum

INDUSTRY

lead

Dr. David Spaner

OTHER